5532 Zeroderma quarter page advertorial PiF v3.qxp_5532 Zeroderma quarte PRODUCT NEWS
ENTEROSGEL - ORGANIC MINERAL FOR DIGESTIVE HEALTH.
TACKLE THE CAUSES OF GASTROINTESTINAL DISORDERS. Scientifi cally developed to attach or bind to toxins, allergens, pathogens and viruses in the GUT.
FOR CHILDREN & ADULTS Gut nasties are gently and effectively expelled from the body helping towards treatment of diarrhoea, allergies and IBS and protection of the intestinal wall.
ENTEROSGEL can be used long-term without systemic side effects and in conjunction with any medications. ENTEROSGEL is a drug-free oral suspension, medical device class IIA
FREE FROM: Preservatives, colouring, gluten, fat, sugar, lactose, fl avours and sweeteners. Non-allergenic.
ENTEROSGEL is available in tubes 90g for children and tubes 225g and sachets packs (10*15g) for children and adults from Sigma Pharmaceuticals, Alliance Healthcare, Tree of Life
FOR MORE INFORMATION PLEASE VISIT ENTEROSGEL.CO.UK
Thealoz Duo is a new, clinically proven eye drop for the treatment of dry eye. It combines Sodium Hyaluronate with Trehalose, a natural discaccharide which uniquely protects cell membranes from extreme dryness. The result is an artifi cial tear that protects, hydrates and lubricates the ocular surface.
Studies have shown that the addition of Trehalose also improves the residence time on the ocular surface, providing a signifi cantly greater improvement in dry eye symptoms compared with hyaluronic acid alone.
Thealoz Duo is the latest addition to Thea Pharmaceutical’s innovative preservative free range (www.thea-pharmaceuticals.co.uk
) and is available in the ABAK® bottle – RRP £13.99 for 300 drops (NHS price) – and 30 unit doses for £9.99. Both products are also available on prescription.
1. Pinto-Bonilla JC et al. Ther Clin Risk Manag 2015;11:595-603 2. Luyckx J & Baudouin C. Clinical Ophthalmology 3. Schmidl D et al. Cornea 2015;34(4):421-6 4. Doan S et al. Acta Ophthamologica 2015; 93, Supplement S255
PIP CODE:392-7412 392-7134
By changing from branded emollients to the cost effective Zeroderma emollient range, NHS Scotland could save £1 million a year and one Scottish Health Board could save around £200,000 p.a.
The Zeroderma range of eight emollients are similar in formulation to around 50% of currently prescribed emollients and offer cost savings of up to 37%. They are all sodium lauryl sulphate (SLS) free and available on prescription.
Many Health Boards and Clinical Commissioning Groups (CCGs) have adopted the Zeroderma range onto their formularies and cost savings are being made without compromising on patient care.
To find out how much your Health Board could save visit our QIPP and Emollients toolkit at www.qipp.trderma.co.uk
, developed by Medicines Management teams it contains everything needed to implement product changes at practice level, as well as a guide to the savings your Health Board could make.
For further information or patient evaluation samples, email: firstname.lastname@example.org
or visit www.trderma.co.uk
Thornton & Ross, Linthwaite, Huddersfield. HD7 5QH Phone: 01484 842217 | Web: www.trderma.co.uk
Up to £1 million savings for NHS Scotland with Zeroderma
The best skincare routine is the one that the patient can adhere to
DOUBLEBASE DAYLEVE GEL –ENHANCED EMOLLIENT GEL
• Enhanced gel formulation with a high level of glycerol and the addition of povidone for proven long lasting emolliency4
• After 5 days, the skin was approximately 5 times more hydrated than with a comparator cream when applied twice daily4
• Designed to encourage patient compliance, by reducing the number of applications required for effective therapy
Doublebase DAYLEVE Gel’s proven 12 hour action means that even when patients only apply their emollient twice a day, you can have the confi dence that their skin will stay moisturised and protected throughout the day, or night.
“The key to emollient therapy is education and tailoring the treatment to the individual child.”
Cork et al. An audit of adverse drug reactions to aqueous cream in children with atopic eczema.
“Adherence to an emollient regimen has the potential to reduce the
need for more expensive treatments and associated GP consultations.”
National Institute for Health and Care Excellence (2007)
Doublebase DAYLEVE Gel – Proven effectiveness with the convenience of twice a day application
SCOTTISH PHARMACIST - 59
| Page 2
| Page 3
| Page 4
| Page 5
| Page 6
| Page 7
| Page 8
| Page 9
| Page 10
| Page 11
| Page 12
| Page 13
| Page 14
| Page 15
| Page 16
| Page 17
| Page 18
| Page 19
| Page 20
| Page 21
| Page 22
| Page 23
| Page 24
| Page 25
| Page 26
| Page 27
| Page 28
| Page 29
| Page 30
| Page 31
| Page 32
| Page 33
| Page 34
| Page 35
| Page 36
| Page 37
| Page 38
| Page 39
| Page 40
| Page 41
| Page 42
| Page 43
| Page 44
| Page 45
| Page 46
| Page 47
| Page 48
| Page 49
| Page 50
| Page 51
| Page 52
| Page 53
| Page 54
| Page 55
| Page 56
| Page 57
| Page 58
| Page 59
| Page 60
| Page 61
| Page 62
| Page 63
| Page 64